NLRP3 and lung carcinoma: Similarly, activation of NLRP3 inflammasome in mesothelial cells of lung cancer leads to an inflammatory response that fuels cancer initiation and progression (21) and then activates the NF-κB-signaling pathway in lung cancer, consequently increasing proliferation and inhibiting apoptosis (54).